Back to Journals » OncoTargets and Therapy » Volume 7

ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression

Total article views   HTML views PDF downloads Totals
9,871 Dovepress* 8,705+ 2,391 11,096
PubMed Central* 1,166 395 1,561
Totals 9,871 2,786 12,657
*Since 18 June 2014
+Since July 2016

View citations on PubMed Central and Google Scholar